Evolocumab Subcutaneous Injection 140 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Subcutaneous Injection
Available Strengths: 140 mg/mL
Reference Brands: Repatha(US & EU)
Category: Heart Disorder
Evolocumab is a monoclonal antibody that inhibits PCSK9, increasing LDL receptor availability to clear LDL cholesterol from the blood. It effectively lowers LDL cholesterol levels, reduces cardiovascular risk, and supports long-term lipid management. Benefits include significant LDL reductions, improved heart health, and prevention of atherosclerotic events.
Product Description: Evolocumab, marketed as Repatha, is approved in the US by the FDA and in the EU via EMA for lowering LDL cholesterol in patients with familial hypercholesterolemia or cardiovascular disease. Regulatory approval requires a detailed dossier including clinical trial efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical and quality documents, while the EMA assesses regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring regional adherence supports timely approval, safe use, and global availability of evolocumab, helping improve cardiovascular health outcomes worldwide.
Evolocumab Subcutaneous Injection — third party manufacturing & bulk supply
Evolocumab Subcutaneous Injection 140 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Evolocumab Subcutaneous Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Evolocumab Subcutaneous Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Trandolapril
Strength:
0.5 mg, 1 mg, 2 mg
Form: Tablets
Reference Brands: Mavik (USA), Gopten (EU)
View Details
Tirofiban Hydrochloride
Strength:
2.5 mg/mL
Form: Injection
Reference Brands: Aggrastat (USA)
View Details
Selexipag
Strength:
200 mcg, 400 mcg, 600 mcg, 800 mcg, 1000 mcg, 1200 mcg, 1400 mcg, 1600 mcg
Form: Tablets / Injection
Reference Brands: Uptravi (USA/EU)
View Details
Edoxaban
Strength:
15 mg, 30 mg, 60 mg
Form: Tablets
Reference Brands: Savaysa (USA), Lixiana (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
